This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Tumor-related interleukins: old validated targets for new anti-cancer drug development
Molecular Cancer Open Access 19 September 2017
-
In-vitro influence of mycophenolate mofetil (MMF) and Ciclosporin A (CsA) on cytokine induced killer (CIK) cell immunotherapy
Journal of Translational Medicine Open Access 13 September 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rettinger E, Willasch AM, Kreyenberg H, Borkhardt A, Holter W, Kremens B et al. Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation. Blood 2011; 118: 5681–568.
Sangiolo D, Mesiano G, Carnevale-Schianca F, Piacibello W, Aglietta M, Cignetti A . Cytokine induced killer cells as adoptive immunotherapy strategy to augment graft versus tumor after hematopoietic cell transplantation. Expert Opin Biol Ther 2009; 9: 831–840.
Pievani A, Borleri G, Pende D, Moretta L, Rambaldi A, Golay J et al. Dual-functional capability of CD3(+)CD56(+) CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity. Blood 2011; 118: 3301–3310.
Introna M, Borleri G, Conti E, Franceschetti M, Barbui AM, Broady R et al. Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study. Haematologica 2007; 92: 952–959.
Linn YC, Niam M, Chu S, Choong A, Yong HX, Heng KK et al. The anti-tumor activity of allogeneic cytokine-induced killer cells in patients who relapse after allogeneic transplant for haematological malignancies. Bone Marrow Transplant 2012; 47: 957–966.
Mesiano G, Todorovic M, Gammaitoni L, Leuci V, Giraudo Diego L, Carnevale-Schianca F et al. Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors. Expert Opin Biol Ther 2012; 12: 673–684.
Rettinger E, Kuci S, Naumann I, Becker P, Kreyenberg H, Anzaghe M et al. The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells. Cytotherapy 2012; 14: 91–103.
Koenig M, Huenecke S, Salzmann-Manrique E, Esser R, Quaritsch R, Steinhilber D et al. Multivariate analyses of immune reconstitution in children after allo-SCT: risk-estimation based on age-matched leukocyte sub-populations. Bone Marrow Transplant 2010; 45: 613–621.
Bader P, Kreyenberg H, Hoelle W, Dueckers G, Handgretinger R, Lang P et al. Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy? J Clin Oncol 2004; 22: 1696–1705.
Laport GG, Sheehan K, Baker J, Armstrong R, Wong RM, Lowsky R et al. Adoptive immunotherapy with cytokine-induced killer cells for patients with relapsed hematologic malignancies after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2011; 17: 1679–1687.
Acknowledgements
We thank the LOEWE Center for Cell and Gene Therapy Frankfurt/Main and the Hessian Ministry of Higher Education, Research and the Arts (HMWK); Funding Reference no.: III L 4–518/17.004 (2010). LOEWE Center for Cell and Gene Therapy Frankfurt/Main and the Hessian Ministry of Higher Education, Research and the Arts (HMWK); Funding Ref. no.: III L 4–518/17.004 (2010) and the Else Kröner-Fresenius-Stiftung (P65/09//A112/09) for the kind support of this work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Rettinger, E., Bonig, H., Wehner, S. et al. Feasibility of IL-15-activated cytokine-induced killer cell infusions after haploidentical stem cell transplantation. Bone Marrow Transplant 48, 1141–1143 (2013). https://doi.org/10.1038/bmt.2013.19
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2013.19
This article is cited by
-
Ex vivo expansion of autologous, donor-derived NK-, γδT-, and cytokine induced killer (CIK) cells post haploidentical hematopoietic stem cell transplantation results in increased antitumor activity
Bone Marrow Transplantation (2019)
-
Tumor-related interleukins: old validated targets for new anti-cancer drug development
Molecular Cancer (2017)
-
In-vitro influence of mycophenolate mofetil (MMF) and Ciclosporin A (CsA) on cytokine induced killer (CIK) cell immunotherapy
Journal of Translational Medicine (2016)
-
A comparison between cytokine- and bead-stimulated polyclonal T cells: the superiority of each and their possible complementary role
Cytotechnology (2016)